ScoreWhy is Amrutanjan Health Care Ltd ?
1
High Management Efficiency with a high ROE of 18.42%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Poor long term growth as Net Sales has grown by an annual rate of 8.59% and Operating profit at -0.48% over the last 5 years
4
The company has declared Positive results for the last 4 consecutive quarters
- NET SALES(Q) Highest at Rs 149.77 cr
- PBDIT(Q) Highest at Rs 25.55 cr.
- PBT LESS OI(Q) Highest at Rs 23.90 cr.
5
Stock is technically in a Mildly Bearish range
- Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
6
With ROE of 18.9, it has a Attractive valuation with a 4.7 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -22.94%, its profits have risen by 27.2% ; the PEG ratio of the company is 0.9
7
Majority shareholders : Promoters
8
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -22.94% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Amrutanjan Healt should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Amrutanjan Healt for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Amrutanjan Healt
-23.35%
-0.74
30.97%
Sensex
-5.6%
-0.64
13.06%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.59%
EBIT Growth (5y)
-0.48%
EBIT to Interest (avg)
56.33
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.18
Sales to Capital Employed (avg)
1.45
Tax Ratio
25.63%
Dividend Payout Ratio
26.16%
Pledged Shares
0
Institutional Holding
14.84%
ROCE (avg)
33.76%
ROE (avg)
18.42%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
25
Industry P/E
34
Price to Book Value
4.65
EV to EBIT
22.03
EV to EBITDA
20.19
EV to Capital Employed
5.44
EV to Sales
3.04
PEG Ratio
0.90
Dividend Yield
0.84%
ROCE (Latest)
21.24%
ROE (Latest)
18.91%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
NET SALES(Q)
Highest at Rs 149.77 cr
PBDIT(Q)
Highest at Rs 25.55 cr.
PBT LESS OI(Q)
Highest at Rs 23.90 cr.
PAT(Q)
Highest at Rs 22.05 cr.
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Amrutanjan Healt
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 23.90 cr has Grown at 49.00%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 22.05 cr has Grown at 45.3%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 149.77 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 25.55 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 23.90 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 22.05 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
